Filing Details

Accession Number:
0001209191-23-008065
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-02-09 17:04:49
Reporting Period:
2023-02-07
Accepted Time:
2023-02-09 17:04:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1564406 Oak Street Health Inc. OSH Services-Health Services (8000) 843446686
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1793313 M Geoffrey Price C/O Oak Street Health, Inc.
30 W. Monroe St., Suite 1200
Chicago IL 60603
Chief Innovation Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2023-02-07 400,000 $21.00 4,274,863 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2023-02-07 400,000 $34.07 3,874,863 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.001 Employee Stock Option (Right to Buy) Disposition 2023-02-07 400,000 $21.00 400,000 $21.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,149,281 2030-08-05 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value 1,073,270 Indirect By Price-Uhl Living Trust
Footnotes
  1. The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.9883 to $34.0980, inclusive. The Reporting Person undertakes to provide to Oak Street Health, Inc., any security holder of Oak Street Health, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote (2).
  3. All options exercised by the Reporting Person as reported in this Form 4 were fully vested and exercisable at the time of the transaction.
  4. The reported securities include the aggregate options, all of which were issued at the time of the Issuer's initial public offering, held by the Reporting Person, a portion of which remains subject to vesting.